Skip to main content

Intellia Therapeutics, Inc. (NASDAQ: NTLA) Investor Securities Class Action Lawsuit 02/11/2025

  • If you purchased a significant amount of shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) between July 30, 2024 to January 8, 2025, and / or if you purchased anyNASDAQ: NTLA shares prior to July 2024 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: April 14, 2025. NASDAQ: NTLA investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

FEbruary 11, 2025 - An investor in shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Intellia Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between July 30, 2024 to January 8, 2025.   Cambridge, MA based In...



You must register (for free) or login to view the entire case.